Skip to main content
hello world

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Lilly to Divest BAQSIMI to Amphastar

PR Newswire - Mon Apr 24, 2023

Lilly focused on delivering the company's unprecedented pipeline of next-generation medicines to help patients

Amphastar is the ideal company to continue Lilly's mission to help more people benefit from BAQSIMI

Read more at prnewswire.com